VT ablation in heart failure | JoVE Visualize

Area of Science:

Cardiology
Electrophysiology
Medical Devices

Background:

Ventricular tachycardias (VT) and implantable cardioverter-defibrillator (ICD) shocks, especially in clusters, are linked to increased hospitalization and mortality.
VT clusters correlate with heart failure exacerbation, acute coronary events, and electrolyte imbalances, but causative factors remain unclear.
The progressive nature of ventricular dysrhythmias in susceptible patients and the high recurrence rates of electrical storm despite antiarrhythmic drugs suggest underlying substrate issues.

Purpose of the Study:

To evaluate the current practices and evidence regarding the optimal timing of ventricular tachycardia (VT) ablation in patients with implantable cardioverter-defibrillators (ICDs).
To explore the potential benefits of preemptive VT ablation before the occurrence of VT episodes or electrical storm.
To challenge the conventional approach of ablating VT only after recurrent or incessant episodes.

Main Methods:

Review of current clinical guidelines and available data on ventricular tachycardia (VT) ablation timing in implantable cardioverter-defibrillator (ICD) patients.
Analysis of the association between VT clusters and adverse clinical outcomes, including heart failure, coronary events, and electrolyte disturbances.
Examination of the efficacy of antiarrhythmic drug therapy versus ablation in managing electrical storm and recurrent VT.

Main Results:

Current guidelines recommend VT ablation primarily after shock clusters or incessant VT, with preemptive ablation performed infrequently (15% of centers).
Strong data supports the efficacy of preemptive VT ablation, suggesting it could be a viable strategy.
The high recurrence rate of electrical storm despite antiarrhythmic drugs indicates a need for more definitive interventions.

Conclusions:

Conventional practice delays VT ablation, often until after significant adverse events occur.
Preemptive VT ablation, though rarely performed, shows promise and warrants further investigation.
Current guidelines may not fully reflect the potential benefits of early intervention for ventricular arrhythmias in ICD patients.